Story Poster
Clemson Baseball

Clemson Sweeps No. 4 Louisville With 15-5 Win

May 3, 2021
1,789

CLEMSON, S.C. - Behind 18 hits, Clemson defeated No. 4 Louisville 15-5 at Doug Kingsmore Stadium on Sunday afternoon. The Tigers, who swept the series 3-0 by a combined score of 31-12, won their sixth game in a row and improved to 21-18 overall and 15-12 in the ACC. The Cardinals dropped to 23-14 overall and 14-9 in ACC play. The Tigers handed Louisville its first three-game sweep since joining the ACC in 2015 and its first three-game sweep since 2011.

Cooper Bowman, Henry Davis and Lucas Dunn all hit solo homers in the top of the first inning. In the bottom of the first inning, Clemson responded with five runs, keyed by four consecutive singles, including run-scoring singles by Caden Grice and Adam Hackenberg, and Davis Sharpe's three-run homer, his third of the year. Grice, who was 4-for-4 with two walks, hit another run-scoring single in the second inning, then the Cardinals scored an unearned run after an error in the top of the third inning.

In the bottom of the third inning, the Tigers scored two runs without a hit to take an 8-4 lead. After Alex Binelas belted a solo homer in the top of the fifth inning, Clemson scored four runs in the bottom of the fifth inning after the first two batters were retired. Bryce Teodosio crushed a solo homer, his fifth of the year, then Kier Meredith, James Parker and Hackenberg added run-scoring doubles. Clemson added a run in the seventh inning and two runs in the eighth inning.

Rob Hughes (1-0) pitched 1.1 innings in relief to earn his first win as a Tiger. Louisville starter Luke Smith (3-3) suffered the loss.

The Tigers host USC Upstate on Wednesday at 6 p.m. on ACC Network Extra.

Discussion from...

Clemson Sweeps No. 4 Louisville With 15-5 Win

1,779 Views | 0 Replies | Last: 2 yr ago by CU Athletic Communications
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.